“showed a trend”

2C ), and showed a trend towards greater activity in the no-boating treatment ( t 20.0 = 1.91, p = 0.071; Fig. 2D ).

IL-12 was the only cytokine that showed a trend of higher PHA-induced production in controllers relative to the HCs ( P= 0.071, Figure 5E ).

And iMFV/cMFV ≥1.12 showed a trend for independently predicting END VCE and sICH (OR: 4.09, 95% CI: 0.89–18.94, P = 0.071).

Dysphagia grade III six months after treatment showed a trend toward worse survival ( p = 0.071).

It was found that the high CRP/Alb ratio showed a trend to correlate with multiple metastasis ( p = 0.071) and elevated LDH level ( p = 0.069), with marginal statistical significance.

Overall in the 11 NUCs treated patients MiR-B-Index showed a trend to improve [BL vs post-T-FU median values −5.86 (−13.39/6.57) vs 0.12 (−8.41/9.46), p = 0.071].

However, LSL in the 50th/52nd week of age showed a trend towards a significant difference ( p = 0.071).

In the T2D cohort, semaglutide was not associated with osteoporosis risk versus any individual comparator, though the comparison with empagliflozin showed a trend (HR 0.90, 95% CI: 0.81–1.01; p = 0.071).

HIF-1alpha at T1 showed a trend toward better OS, with a median of 101 months in T2 + T3, whereas it was not reached in T1 ( p = 0.071).

For life evaluation (the evaluative component of SWB), the results only showed a trend to significant differences (F(3,332) = 2.37, p = .071).

The lymph node clusters LN1-LN4 were significantly correlated with lymph node status ( p = 0.01) and showed a trend towards differences in primary tumour and metastatic size ( p = 0.071) but not with other clinical parameters such as metastasis size and primary tumour size (Fig. 3b, e, f , Supplementary Fig. 3B ).

Additionally, patients with AMI of ≥ 15 cm2/m2 showed a trend toward increased risk (adjusted OR 2.088, p = 0.071).

Meanwhile, OS also showed a trend toward worse outcomes in the EBER-negative group, albeit without significance (82.0% [95% CI, 70.3%−95.6%] vs. 89.2% [95% CI, 83.7%−95.1%], P = 0.071, Fig. 3 D).

SGM cancer survivors with cardiovascular disease showed a trend ( p = 0.071) toward lower odds of living in a state with protective policies (AOR: 0.89; 95% CI: 0.78–1.01).

Clinical parameters such as the Charlson Comorbidity Index showed a trend toward higher values in the slow gait speed group (4.0 [3.0–5.0] vs. 2.0 [0.0–4.0], p = 0.071) but did not reach statistical significance.

Comparing these 15 patients with the other seven LGL L-associated PRCA patients who were negative for STAT3 mutation, the clinical features did not differ (data not shown), although those with mutations showed a trend towards a younger age than those without mutations (median age, 52.5 years and 77.5 years, respectively; P = 0.071).

Results At follow-up, participants spent less time doing vigorous physical activity (∆ = −76 ± 157 min·wk −1 , P = 0.048), exhibited a tendency toward increased sedentary time (∆ = +120 ± 162 min·d −1 , P = 0.056), weighed more (∆ = +2.5 ± 2.8 kg, P = 0.021), and showed a trend toward reduced quadriceps strength (∆ = −0.29 ± 0.45 (N·m)·kg −1 , P = 0.071) compared with baseline.

Rebleeding rates did not differ between EBL and EVO in three studies [ 13 , 14 , 21 ], while one study showed a trend for higher rebleeding rates in the EBL group than in the EVO group (16.0% vs. 6.7%, P =0.071) [ 20 ].

Time spent in close inspection was significantly affected by the block ( p = 0.014) and showed a trend towards a condition effect ( p = 0.071, both species tended to show more close inspection towards the mirror than the control).

Additionally, the RE group showed a trend of higher milk fat content compared to the CON group ( P = 0.071) ( Table 2 ).

However, the change in SWE compared to T0 showed a trend at T1 (7.7 ± 15.7 kPa vs −4.1 ± 12.0 kPa, P = .071) and was significantly different at T2 between sigmoid endoscopic responders and non-responders (9.9 ± 11.5 kPa vs −8.1 ± 11.4 kPa, P = .002; Table 6 , Figure 4 ). 3.5.2.

Regarding distant control, while the HAIC cohort (90.3%) showed a trend toward better control compared to the systemic therapy cohort (72.7%), the difference was not statistically significant ( P = 0.071).At the first reassessment (C2, Supplementary Table 2 ), most patients remained at stage IV with multiple metastases, and intergroup differences in tumor burden or hematologic indices were not significant.

The adjusted multivariate analysis failed to reach statistical significance for the primary or the secondary endpoints but showed a trend towards a higher incidence of POCE in patients with eGFR < 60 mL/min/1.73 m 2 , with a HR of 1.56 (95% CI 0.96–2.53; p = 0.071), and towards more frequent unplanned revascularizations (HR 1.91; 95% CI 0.93–3.93; p = 0.078).

In this case, a trend toward significance suggested the inclusion of time ( χ 2 (4) = 8.4, p = 0.077), where the evaluation at T2 showed a trend toward improvement compared to the baseline ( p = 0.071), probably as an effect of the task repetition since the assessment was repeated in a shorter time (every month) up to T2 and then with longer time intervals (see Figure 3 ).

Repeated-measures ANOVA across all sessions and all four groups showed a trend toward group differences (F(3, 31) = 2.59, p = 0.071), without a significant group × session interaction (F(27, 279) = 0.89, p = 0.63).